Epidemiology of Endometriosis: a Large Population-based Database Study from a Healthcare Provider with 2 Million Members
Overview
Authors
Affiliations
Objective: Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real-world epidemiology of endometriosis in an unselected low-risk population in Israel.
Design: Retrospective population-based study.
Setting And Sample: The computerised databases of Maccabi Healthcare Services (MHS), a 2-million-member healthcare provider representing a quarter of the Israeli population.
Methods: The crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000-2015) rates of diagnosed endometriosis (ICD-9-CM 617.xx) were assessed among women aged 15-55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries.
Main Outcome Measures: Prevalence and incidence of diagnosed endometriosis in MHS.
Results: The point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5-11.0). Women aged 40-44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7-19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly-diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5-8.0).
Conclusions: We observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high-risk populations, in line with population-based estimates from European databases (range 0.8-1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice.
Tweetable Abstract: Endometriosis diagnosed in 1% of women, according to a large population-based study in a community setting.
Systematic review on the DNA methylation role in endometriosis: current evidence and perspectives.
Ducreux B, Patrat C, Firmin J, Ferreux L, Chapron C, Marcellin L Clin Epigenetics. 2025; 17(1):32.
PMID: 39985111 PMC: 11846336. DOI: 10.1186/s13148-025-01828-w.
Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review.
Dayan D, Ebner F, Janni W, Hancke K, Adiyaman D, Huener B J Clin Med. 2025; 13(24.
PMID: 39768455 PMC: 11727832. DOI: 10.3390/jcm13247530.
Evaluation of the Epidemiological Disease Burden and Nationwide Cost of Endometriosis in Hungary.
Ponusz-Kovacs D, Ponusz R, Santics-Kajos L, Csakvari T, Kovacs B, Varnagy A Healthcare (Basel). 2025; 12(24.
PMID: 39765994 PMC: 11675645. DOI: 10.3390/healthcare12242567.
Predictors of anxiety in endometriosis patients.
Kupec T, Wagels L, Caspers R, Meyer-Wilmes P, Najjari L, Stickeler E Arch Gynecol Obstet. 2024; .
PMID: 39725706 DOI: 10.1007/s00404-024-07878-4.
Xu T, Zhuang Y, Cao H Reprod Health. 2024; 21(1):158.
PMID: 39497169 PMC: 11536846. DOI: 10.1186/s12978-024-01895-x.